Procept biorobotics stock.
In terms of sales, PROCEPT BioRobotics achieved quarterly revenues of $35.10 million, exceeding the analyst consensus estimate of $33.09 million by 6.08 percent. This represents an impressive 72.50 percent increase compared to the $20.35 million in sales recorded during the same period last year. These results highlight the company’s ...
14 พ.ค. 2566 ... Silicon Motion (SIMO): Silicon Motion enjoys a zero-debt balance sheet. Procept BioRobotics (PRCT): Procept benefits from high fiscal stability.PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with …PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance Provided by GlobeNewswire. Nov 1, 2023 8:02 PM UTC ... Stock-based compensation expense ...Mar 10, 2023 · Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently down 17.97% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $29.82. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $22.98 ... SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third... 12 Oct '23.
REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...Procept BioRobotics Main Entrance. SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on developing transformative solutions in urology, proudly announces the grand opening of its state-of-the-art global corporate headquarters in ...
Complete PROCEPT BioRobotics Corp. stock information by Barron's. View real-time PRCT stock price and news, along with industry-best analysis.
Procept Biorobotics reels in $85M to make a splash with water-based robotic system for prostate surgery By Andrea Park Jun 30, 2021 10:00am Aquablation benign prostatic hyperplasia medical device ...REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended December 31, 2022.. Recent Highlights . …PROCEPT BioRobotics Corporation (PRCT) Stock Price | Stock Quote Nasdaq - MarketScreener PROCEPT BIOROBOTICS CORPORATION PDF Report …SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023.Nov 30, 2023 · The stock of Procept BioRobotics Corp (PRCT) has gone up by 9.73% for the week, with a 48.65% rise in the past month and a 9.92% rise in the past quarter. The volatility ratio for the week is 4.42%, and the volatility levels for the past 30 days are 5.89% for PRCT. The simple moving […]
Aug 1, 2023 · PROCEPT BioRobotics also expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s ( PRCT) price is currently down 7.58% so far this month. During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $34.37. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as …
PROCEPT BioRobotics reports unaudited financial results for Q3 2023, with total revenue of $35.1 million, a 72% increase YoY. U.S. handpiece and consumables revenue reached $17.0 million, up 113% YoY. Monthly account utilization increased by 5% compared to Q2 2023. The company sold 38 U.S. robotic systems, with robotic system …REDWOOD CITY, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by ...Full Year 2022 Financial Results. Revenue for the full year 2022 was $75.0 million, compared to $34.5 million for the full year 2021. The growth was primarily driven by increases in U.S. revenues, attributable to system placements and increased utilization. Gross margin for full year 2022 was 49%, compared to 46% for the full year 2021.On January 9, 2023, PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.PROCEPT BioRobotics Corporation is a surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with …Dec 2, 2023 · Procept BioRobotics Corp (PRCT) registered a 0.78% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.78% in intraday trading to $37.36 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is 5.69%, and it has moved by 35.61% in 30 days. CharlieAJA/iStock via Getty Images. Procept BioRobotics ( NASDAQ: PRCT) is down 19% in early Thursday afternoon trading after its Q1 2023 financial results missed on the bottom line. The medical ...
PROCEPT BioRobotics also expects to grant the underwriters a 30-day option to purchase up to an additional $18,750,000 of shares of its common stock. The …PRCT PROCEPT BioRobotics Corporation Stock Price & Overview $26.22 -1.32 ( -4.79%) 4:00 PM 10/25/23 NASDAQ | $USD | Pre-Market: $26.13 -0.09 (-0.34%) 7:05 AM Summary Ratings Financials...PROCEPT BioRobotics Corp PRCT Morningstar Rating Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...See Insiders’ Hot Stocks on TipRanks >> PROCEPT BioRobotics (PRCT) ... Currently, the analyst consensus on PROCEPT BioRobotics is a Strong Buy with an average price target of $48.75, a 46.8% ...
Oct 25, 2023 · PROCEPT BioRobotics Corporation appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead ... PROCEPT BioRobotics Stock Performance. NASDAQ:PRCT opened at $33.77 on Wednesday. The stock has a 50-day simple moving average of $31.03 and a two-hundred day simple moving average of $32.99 ...
PROCEPT BioRobotics develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial ...PROCEPT BioRobotics Corporation (PRCT) Stock Historical Prices & Data - Yahoo Finance S&P 500 (+0.10%) Dow 30 -40.33(-0.12%) Nasdaq +10.56(+0.08%) Russell 2000 -19.08(-1.10%) Crude Oil... Description. PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus …Aug 4, 2022 · PROCEPT BioRobotics will host a conference call to discuss the second quarter 2022 financial results after the market close on Thursday, August 4th, 2022, at 1:30 p.m. Pacific Time / 4:30 p.m ... SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by ...May 30, 2023 · imaginima. PROCEPT BioRobotics ( NASDAQ: PRCT) is an interesting play on the continued trend of lesser invasive procedures for common health problems. The medical device sector has increased in ... SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2023.REDWOOD CITY, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended March 31, 2022. Recent …
Nov 29, 2023 · 6 brokers have issued 12 month price objectives for PROCEPT BioRobotics' stock. Their PRCT share price targets range from $37.00 to $49.00. On average, they predict the company's share price to reach $43.00 in the next twelve months. This suggests a possible upside of 23.9% from the stock's current price.
PROCEPT BioRobotics Corporation (PRCT) Stock Historical Prices & Data - Yahoo Finance S&P 500 (+0.10%) Dow 30 -40.33(-0.12%) Nasdaq +10.56(+0.08%) Russell 2000 -19.08(-1.10%) Crude Oil...
PROCEPT BioRobotics also completed an equity follow-on offering, raising $162 million in net proceeds, and received FDA IDE approval for Aquablation Therapy for Prostate Cancer. PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance | PRCT Stock NewsStocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...The PROCEPT BioRobotics 52-week low stock price is $24.83. What is the market capitalisation of PROCEPT BioRobotics PRCT? As of 01/12/2023 PROCEPT BioRobotics has a market cap of $1.9B.PROCEPT BioRobotics develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial ...PROCEPT BioRobotics Corporation doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with …PROCEPT BioRobotics’ stock opened at a price of $33.27 on Friday. The company boasts a current ratio of 6.40 and a quick ratio of 5.21 while maintaining a debt-to-equity ratio of 0.34. Notably, the company’s fifty-day simple moving average stands at $33.35 with a 200-day simple moving average at $33.23.PROCEPT BioRobotics Corporation has gained recognition as a pioneering force in the field of surgical robotics, specializing in transformative solutions for urology. ... Kevin Waters executed a transaction on June 15th, selling 22,631 shares of PROCEPT BioRobotics stock at an average price of $35.12 per share. The total value of this ...
PROCEPT BioRobotics last announced its quarterly earnings results on November 1st, 2023. The reported ($0.51) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.53) by $0.02. The company had revenue of $35.10 million for the quarter, compared to the consensus estimate of $33.44 million.CharlieAJA/iStock via Getty Images. Procept BioRobotics ( NASDAQ: PRCT) is down 19% in early Thursday afternoon trading after its Q1 2023 financial results missed on the bottom line. The medical ...Procept Biorobotics Corp Stock Price History. Procept Biorobotics Corp’s price is currently up 24.96% so far this month. During the month of April, Procept Biorobotics Corp’s stock price has reached a high of $35.90 and a low of $28.80. Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as …The PROCEPT BioRobotics 52-week low stock price is $24.83. What is the market capitalisation of PROCEPT BioRobotics PRCT? As of 01/12/2023 PROCEPT BioRobotics has a market cap of $1.9B.Instagram:https://instagram. rtx corpwho.owns modelo beerhow much is a silver brick worthhcmcs PROCEPT BioRobotics Corporation (PRCT) Stock Historical Prices & Data - Yahoo Finance S&P 500 (+0.10%) Dow 30 -40.33(-0.12%) Nasdaq +10.56(+0.08%) Russell 2000 -19.08(-1.10%) Crude Oil...SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third... 12 Oct '23. ewz stocksbitf stock price The most recent slide in PROCEPT BioRobotics stock may reflect the dawning recognition from other investors that perhaps the share price is a bit too rich. After all, the company’s immediate market is less than $1 billion, according to our math. world wasr 3 Jan 9, 2023 · On January 9, 2023, PROCEPT BioRobotics Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. PROCEPT BioRobotics Corporation: RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA (Unaudited, in thousands) Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net loss $ (25,285) $ (19,184) $ (53,771) $ (36,369) Depreciation and amortization expense 642 717 1,435 1,475 Stock-based compensation expense 5,104 2,676 8,827 ...